About This Deal
BIO-RAD LABORATORIES, INC. acquired DiaMed Benelux for 4.6 million Euros (approximately $5.6 million) in cash, a transaction completed in July 2012, structured as all cash.
DiaMed Benelux operates in Clinical Diagnostics, is based in Benelux (Belgium / Netherlands / Luxembourg). In July 2012, Bio-Rad acquired all of the outstanding shares of DiaMed Benelux, extending its DiaMed blood-typing diagnostics franchise in the Benelux region.
Clinical Diagnostics segment
Deal Terms
Acquirer
BIO-RAD LABORATORIES, INC.
Target
DiaMed Benelux
Value
4.6 million Euros (approximately $5.6 million) in cash
Date
July 2012
Type
Full acquisition
Status
Ready
Transaction Details
Target HQ
Benelux (Belgium / Netherlands / Luxembourg)
Segment
Clinical Diagnostics
Structure
All cash
Announced
July 1, 2012
Closed
July 1, 2012
In Their Words
In July 2012, we acquired all of the outstanding shares of DiaMed Benelux for 4.6 million Euros (approximately $5.6 million) in cash.Bio-Rad Laboratories FY2014 10-K, acquisitions disclosure
Advisors
Advisory firms were not disclosed for this transaction.
Related Deals & Entities
Sources:
Press release ↗
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.